Artikel ; Online: Inhibiting fusion with cellular membrane system: therapeutic options to prevent severe acute respiratory syndrome coronavirus-2 infection.
American journal of physiology. Cell physiology
2020 Band 319, Heft 3, Seite(n) C500–C509
Abstract: Severe acute respiratory syndrome coronavirus (SARS-CoV), an enveloped virus with a positive-sense single-stranded RNA genome, facilitates the host cell entry through intricate interactions with proteins and lipids of the cell membrane. The detailed ... ...
Abstract | Severe acute respiratory syndrome coronavirus (SARS-CoV), an enveloped virus with a positive-sense single-stranded RNA genome, facilitates the host cell entry through intricate interactions with proteins and lipids of the cell membrane. The detailed molecular mechanism involves binding to the host cell receptor and fusion at the plasma membrane or after being trafficked to late endosomes under favorable environmental conditions. A crucial event in the process is the proteolytic cleavage of the viral spike protein by the host's endogenous proteases that releases the fusion peptide enabling fusion with the host cellular membrane system. The present review details the mechanism of viral fusion with the host and highlights the therapeutic options that prevent SARS-CoV-2 entry in humans. |
---|---|
Mesh-Begriff(e) | Amino Acid Sequence ; Angiotensin-Converting Enzyme 2 ; Animals ; Betacoronavirus/drug effects ; Betacoronavirus/metabolism ; COVID-19 ; Cell Membrane/drug effects ; Cell Membrane/metabolism ; Cell Membrane/virology ; Coronavirus Infections/metabolism ; Coronavirus Infections/prevention & control ; Humans ; Pandemics/prevention & control ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/metabolism ; Pneumonia, Viral/prevention & control ; Protease Inhibitors/pharmacology ; Protease Inhibitors/therapeutic use ; Protein Binding/drug effects ; Protein Binding/physiology ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/antagonists & inhibitors ; Spike Glycoprotein, Coronavirus/metabolism ; Viral Fusion Proteins/drug effects ; Viral Fusion Proteins/metabolism |
Chemische Substanzen | Protease Inhibitors ; Spike Glycoprotein, Coronavirus ; Viral Fusion Proteins ; spike protein, SARS-CoV-2 ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) |
Schlagwörter | covid19 |
Sprache | Englisch |
Erscheinungsdatum | 2020-07-20 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 392098-7 |
ISSN | 1522-1563 ; 0363-6143 |
ISSN (online) | 1522-1563 |
ISSN | 0363-6143 |
DOI | 10.1152/ajpcell.00260.2020 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Uc I Zs.89: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.